These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 3810530

  • 1. [Advantages of a microcomputer system in researching duplicated reports].
    Biour M, Wagniart F, Jablonka J, Hamel JD, Weissenburger J, Cheymol G.
    Therapie; 1986; 41(5):383-4. PubMed ID: 3810530
    [No Abstract] [Full Text] [Related]

  • 2. [Microcomputerized data bank of nephrotoxic drugs at the Paris-Saint Antoine Regional Drug Monitoring Center].
    Hamel JD, Biour M, Cheymol G.
    Therapie; 1986; 41(5):327-9. PubMed ID: 3810519
    [No Abstract] [Full Text] [Related]

  • 3. [Drug monitoring].
    Royer RJ.
    Bull Soc Ophtalmol Fr; 1985 Nov; Spec No():11-30. PubMed ID: 4064240
    [No Abstract] [Full Text] [Related]

  • 4. [Information centers on undesirable effects of drugs: also on alerting function].
    Bégaud B, Péré JC, Tubert P, Barat C, Haramburu F, Albin H.
    Therapie; 1987 Nov; 42(2):231-7. PubMed ID: 3617000
    [No Abstract] [Full Text] [Related]

  • 5. [Computerized detection of new adverse effects in drug surveillance. A proposal for the periodic use of the French data bank].
    Pham E, Ventre JJ, Saddier P, Descotes J, Evreux JC.
    Therapie; 1988 May; 43(3):235-7. PubMed ID: 3420571
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Organization and results of drug vigilance in France].
    Bégaud B, Chaslerie A, Haramburu F.
    Rev Epidemiol Sante Publique; 1994 May; 42(5):416-23. PubMed ID: 7973001
    [Abstract] [Full Text] [Related]

  • 11. Statewide test of a new postmarketing drug surveillance system.
    Fisher S, Bryant SG, Solovitz BL, Kluge RM.
    Tex Med; 1987 Aug; 83(8):59-62. PubMed ID: 3660262
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [A searchable data bank on the Minitel system for iatrogenic pathology and drug interactions designed for practitioners].
    Escousse A, Bianchetti D, Sgro C, Parfait S, Perceau JP.
    Therapie; 1987 Aug; 42(1):57. PubMed ID: 3590066
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Monitoring adverse drug reactions in the postmarketing phase.
    Hoigné R, Hottinger S.
    Pharm Acta Helv; 1988 Aug; 63(1):2-12. PubMed ID: 3283774
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. An adverse drug reaction reporting program.
    Wasan SM, Marshall LB.
    Can J Hosp Pharm; 1989 Dec; 42(6):239-41. PubMed ID: 10318356
    [No Abstract] [Full Text] [Related]

  • 20. [Eighth French Drug Surveillance Seminar. Paris, 23-24 October 1986].
    Therapie; 1987 Dec; 42(4):331-410. PubMed ID: 3686465
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.